⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2666838 | 1.00 | — | — | |
| SCHEMBL349778 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL7262247 | 0.97 | — | — | |
| Sulfuric Acid SCHEMBL11562715 | 0.86 | NOS1 (0.43) | — | |
| Sulfuric Acid SCHEMBL11562717 | 0.86 | NOS1 (0.43) | — | |
| SCHEMBL20865510 | 0.76 | — | — | |
| SCHEMBL9296847 | 0.74 | — | — | |
| SCHEMBL14598241 | 0.74 | — | — | |
| SCHEMBL14868270 | 0.74 | NOS1 (0.43) | — | |
| SCHEMBL14868272 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357632-A1 | IONIC LIQUID PEROVSKITE DEVICES | CUBICPV INC. | 2023-11-09 | — | — | US | disclosed |
| US-20230284466-A1 | Perovskite Material Photovoltaic Device and Method for Assembly | CUBICPV INC. | 2023-09-07 | — | — | US | disclosed |
| US-20230271848-A1 | Metal Oxide Nanoparticle With Alkylsiloxane Ligands Bonded Thereto | CUBICPV INC. | 2023-08-31 | — | — | US | disclosed |
| US-11685666-B2 | Metal oxide nanoparticles with alkylsiloxane ligands bonded thereto | CUBICPV INC. (US) | 2023-06-27 | — | — | US | disclosed |
| US-20230167308-A1 | LEAD-SEQUESTRATION MATERIAL FOR PEROVSKITE DEVICES | CUBICPV INC. | 2023-06-01 | — | — | US | disclosed |
| US-20230167326-A1 | Methods for Forming Perovskite Material Layers | CUBICPV INC. | 2023-06-01 | — | — | US | disclosed |
| US-20230162974-A1 | Enhanced Perovskite Materials for Photovoltaic Devices | CUBICPV INC. | 2023-05-25 | — | — | US | disclosed |
| US-11659723-B2 | Perovskite material photovoltaic device and method for assembly | CUBICPV INC. (US) | 2023-05-23 | — | — | US | disclosed |
| US-20230002356-A1 | COMPOUNDS AND USES THEREOF | PANO THERAPEUTICS, INC. (US) | 2023-01-05 | — | — | US | disclosed |
| WO-2021055637-A1 | COMPOUNDS AND USES THEREOF | PANO THERAPEUTICS, INC. (US) | 2021-03-25 | — | — | WO | disclosed |
| EP-2423195-A1 | Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof | LEK Pharmaceuticals d.d. (SI) | 2012-02-29 | — | — | EP | disclosed |
| WO-2012013325-A1 | PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LEK PHARMACEUTICALS D.D. (SI) | 2012-02-02 | — | — | WO | disclosed |
| US-8101636-B2 | Linear dicationic terphenyls and their aza analogues as antiparasitic agents | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2012-01-24 | — | — | US | disclosed |
| US-7964619-B2 | Teraryl components as antiparasitic agents | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2011-06-21 | — | — | US | disclosed |
| EP-1615866-B1 | INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS | AQUINOX PHARMACEUTICALS INC (CA) | 2011-02-16 | — | — | EP | disclosed |
| US-20090005344-A1 | Compounds and Methods of Use Thereof | NKUADA, LLC (US) | 2009-01-01 | — | — | US | disclosed |
| EP-1949896-A2 | Linear dicationic terphenyls and their aza analogues as antiparasitic agents | The University of North Carolina At Chapel Hill (US) | 2008-07-30 | — | — | EP | disclosed |
| US-20070232621-A1 | Linear dicationic terphenyls and their aza analogues as antiparasitic agents | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2007-10-04 | — | — | US | disclosed |
| US-7217815-B2 | 2-beta -modified-6-substituted adenosine analogs and their use as antiviral agents | VALEANT PHARMACEUTICALS NORTH AMERICA (US) | 2007-05-15 | — | — | US | disclosed |
| WO-2006050236-A2 | COMPOUNDS AND METHODS OF USE THEREOF | NUADA, LLC (US) | 2006-05-11 | — | — | WO | disclosed |